Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-09-04Clinical Trial Update: Resveratrol and Type 2 Diabetes [NA]
This is an update on a clinical trial evaluating resveratrol for Type 2 diabetes; the status and phase are not specified.
-
CLINICAL_TRIALS research · 2014-09-04Clinical Trial Update: Chromosomal Damage in Type 2 Diabetes Patients (MIKRODIAB)
A clinical trial update from the University of Vienna regarding chromosomal damage in patients with type 2 diabetes, with cancer also listed…
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: An Efficacy, Safety, and Tolerability Study of Canagliflozin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy [Phase 2]
A Phase 2 study evaluating the efficacy, safety, and tolerability of canagliflozin added to metformin in adults with type 2 diabetes inadequ…
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes [Phase 2]
This Phase 2 trial evaluated MP-513 in combination with metformin for type 2 diabetes and has posted efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial evaluating the addition of ranolazine to glimepiride in subjects with type 2 diabetes mellitus; the study has completed and re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4 [EARLY_Phase 1]
Early Phase 1 trial update investigating metabolic causes of thrombosis in individuals with type 2 diabetes; study completed with posted res…
-
FDA approval · 2014-08-29FDA Approved: RIOMET — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for RIOMET (metformin hydrochloride) from Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS research · 2014-08-29Clinical Trial Update: Type II Diabetes Influence on Left Ventricular Remodeling and Outcomes in Patients Undergoing Aortic Valve Replacement Surgery. [NA]
A clinical trial update describing a study on how Type 2 diabetes mellitus may influence left ventricular remodeling and outcomes after aort…
-
FDA approval · 2014-08-28FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Zydus Lifesciences Limited)
FDA approved the Original Application for Metformin Hydrochloride by Zydus Lifesciences Limited, a generic version of metformin. It is used …
-
CLINICAL_TRIALS trial_result · 2014-08-28Clinical Trial Update: Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187 [Phase 1]
A Phase 1 trial update assessing the safety, tolerability, pharmacokinetics, food effect, and pharmacodynamics of single and multiple doses …
-
CLINICAL_TRIALS trial_result · 2014-08-28Clinical Trial Update: A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects [Phase 1]
A single-dose Phase 1 study of DBPR108 was conducted in healthy male subjects, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes [Phase 2]
Phase 2 trial comparing liraglutide to insulin in patients with type 2 diabetes to assess liver fat fraction in nonalcoholic fatty liver dis…
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM [Phase 1]
The document reports a terminated Phase 1 study assessing concentrations of saxagliptin, its 5-hydroxy metabolite, and metformin in pediatri…
-
FDA approval · 2014-08-25FDA Approved: GLYBURIDE — Supplemental Application (TEVA Pharmaceuticals USA Inc)
FDA approves a supplemental application for glyburide by Teva Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Evaluation of a Primary Type 2 Diabetes Prevention Programme [Phase 4]
Phase 4 evaluation of a primary prevention programme for Type 2 diabetes has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Duodenal Exclusion for the Treatment of T2DM [Phase 4]
This update reports the completion of a Phase 4 clinical trial evaluating duodenal exclusion as a treatment for type 2 diabetes mellitus, sp…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Neuroendocrine Brake for Type 2 Diabetes Mellitus [Phase 4]
A Phase 4 clinical trial evaluating a neuroendocrine brake for Type 2 diabetes mellitus has completed.
-
FDA approval · 2014-08-21FDA Approved: KAZANO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approves a supplemental application for KAZANO (alogliptin and metformin hydrochloride) from Takeda Pharmaceuticals America, Inc. This n…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Diagnostic Biomarkers Related to Periodontal Disease Activity in Diabetic [Phase 3]
Phase 3 clinical trial from the University of Sao Paulo investigating diagnostic biomarkers of periodontal disease activity in people with T…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus [Phase 2]
A Phase 2 safety and efficacy study comparing subcutaneously injected prandial insulins to insulin lispro alone in adults with Type 2 diabet…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: A Study of the Effects of Canagliflozin on Plasma Volume in Patients With Type 2 Diabetes Mellitus [Phase 1]
Phase 1 trial update evaluating the effects of canagliflozin on plasma volume in patients with Type 2 diabetes mellitus. The study status is…
-
CLINICAL_TRIALS trial_result · 2014-08-19Clinical Trial Update: Diabetes & Vardenafil [Phase 2]
Phase 2 clinical trial of Vardenafil in patients with type 2 diabetes mellitus and endothelial dysfunction (including erectile dysfunction) …
-
CLINICAL_TRIALS trial_result · 2014-08-18Clinical Trial Update: Liquid Meal Study With Insulin Lispro With/Without Recombinant Human Hyaluronidase PH20 (rHuPH20) and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Participants With Type 2 Diabetes Mellitus (T2DM) [Phase 2]
Phase 2 clinical trial update evaluating the pharmacokinetics and postprandial glycemic responses of insulin lispro with or without recombin…
-
FDA approval · 2014-08-16FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOPLUS MET, a fixed-dose combination of pioglitazone and metformin HCl, manufactured by Takeda…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.
This completed observational study evaluated the efficacy of Levemir (insulin detemir) in patients with type 2 diabetes.